A NEW tool may be reshaping early diagnosis, as an artificial intelligence programme significantly improved detection of transthyretin cardiac amyloidosis across a large health system. The trial found that targeted AI screening led…
A NEW tool may be reshaping early diagnosis, as an artificial intelligence programme significantly improved detection of transthyretin cardiac amyloidosis across a large health system. The trial found that targeted AI screening led…